Cello Health PLC Block Listing Update & Total Voting Rights (6501T)

TIDMCLL

RNS Number : 6501T

Cello Health PLC

21 July 2020

Cello Health plc

("Cello" or the "Company")

Block Listing Update

Total Voting Rights

The Company notifies that, since the date of its most recent block listing update, a total of 170,667 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing. An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

As at today's date, Cello's issued share capital comprises 107,143,531 ordinary shares of 10 pence each ("Ordinary Shares"), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,690,531 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquires

 
 Cello Health                   020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Group Finance 
  Director 
 
 Cenkos Securities              020 7397 8900 
 Giles Balleny 
 Harry Hargreaves 
 
 Buchanan                       020 7466 5000 
 Mark Court 
 Jamie Hooper 
 Sophie Wills

BLOCK LISTING SIX MONTHLY RETURN

 
 Name of applicant:                      Cello Health plc 
 Name of scheme:                         PSP Option Scheme 2010, Approved 
                                          Share Option Plan 2009 and Unapproved 
                                          Scheme 2010 
                                        ------------------------------------------- 
 Period of return:             From:     21 January       To:    21 July 2020 
                                          2020 
                              --------  ---------------  -----  ------------------- 
 Balance of unallotted securities 
  under scheme(s) from previous 
  return:                                1,685,819 
                                        ------------------------------------------- 
 Plus: The amount by which               - 
  the block scheme(s) has been 
  increased since the date of 
  the last return (if any increase 
  has been applied for): 
                                        ------------------------------------------- 
 Less: Number of securities 
  issued/allotted under scheme(s) 
  during period:                         170,667 
                                        ------------------------------------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at 
  end of period:                         1,515,152 
                                        ------------------------------------------- 
 Name of contact:                        Mark Bentley, Group Finance Director 
                                        ------------------------------------------- 
 Telephone number of contact:            020 7812 8460 
                                        -------------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRPPUQGMUPUGGG

(END) Dow Jones Newswires

July 21, 2020 07:18 ET (11:18 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Sep 2024 to Oct 2024